Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...
Dr. Myro Figura told Newsweek that seeking medical advice on social media "can be not only misleading but also downright ...
The U.S. Justice Department has filed a lawsuit accusing Walgreens of filling millions of prescriptions for Americans over ...
Food companies criticize the science supporting front-of-package labeling, delay public consultation periods, push for their ...
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...
Amid a deluge of executive actions, the Trump administration has directed federal health agencies to pause external ...
The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...
The U.S. Department of Health and Human Services has paused public communications until Feb. 1 as Trump appointees take control of health agencies.
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...
The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ...
In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.